Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Akari Therapeutics PLC AKTX

Healthcare Biotechnology
Akari Therapeutics, Plc is a late-stage biotechnology company. The Company is developing advanced therapies for autoimmune and inflammatory diseases. Its lead asset, investigational nomacopan, is a bispecific recombinant inhibitor of complement C5 activation and leukotriene B4 (LTB4) activity. Its pipeline includes a Phase 3 clinical trial program investigating nomacopan for pediatric... see more

Recent & Breaking News (NDAQ:AKTX)

How These Generic Drugs Stocks are Performing? -- Akari Therapeutics, Flexion Therapeutics, Lannett, and Supernus Pharma

PR Newswire July 31, 2017

AKARI THERAPEUTICS 24 HOUR DEADLINE ALERT: APPROXIMATELY 24 HOURS REMAIN; CLAIMSFILER REMINDS INVESTORS of Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc – (AKTX)

GlobeNewswire July 10, 2017

DEADLINE TOMORROW: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses Exceeding $100,000 to Contact the Firm

GlobeNewswire July 10, 2017

DEADLINE ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Akari Therapeutics Plc (AKTX) & Lead Plaintiff Deadline - July 11, 2017

GlobeNewswire July 10, 2017

AKARI THERAPEUTICS 96 HOUR DEADLINE ALERT: Approximately 96 Hours Remain; Former Louisiana Attorney General and Kahn Swick & Foti, LLC Remind Investors of Deadline in Class Action Lawsuit against Akari Therapeutics, Plc – (AKTX)

Business Wire July 7, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Zoompass Holdings, Inc. of Class Action Lawsuit and Upcoming Deadline – ZPAS

Business Wire July 7, 2017

July 11 Deadline Alert: GPM Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Akari Therapeutics, Plc

Business Wire July 7, 2017

AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm

Business Wire July 5, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Booz Allen Hamilton Holding Corporation – BAH

GlobeNewswire July 5, 2017

AKARI THERAPEUTICS SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Akari Therapeutics, Plc – (AKTX)

GlobeNewswire June 30, 2017

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Akari Therapeutics plc of Class Action Lawsuit and Upcoming Deadline – AKTX

GlobeNewswire June 30, 2017

Akari Notice: Rosen Law Firm Reminds Akari Therapeutics, Plc Investors of Important Deadline in Class Action - AKTX

GlobeNewswire June 23, 2017

Akari Therapeutics to Present Data from Phase 2 PNH Trial of Coversin at the 22nd Congress of the European Hematology Association

GlobeNewswire June 23, 2017

AKARI LEAD PLAINTIFF DEADLINE ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $50,000 In Akari Therapeutics, Plc To Contact The Firm

Business Wire June 19, 2017

AKARI THERAPEUTICS SHAREHOLDER ALERT by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit against Akari Therapeutics, Plc – (AKTX)

Business Wire June 16, 2017

IMPORTANT INVESTOR ALERT: Lundin Law PC Announces Securities Class Action Lawsuit against Mazor Robotics Ltd. and Encourages Investors with Losses to Contact the Firm

Business Wire June 12, 2017

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Class Action Against Intra-Cellular Therapies, Inc. (ITCI) and Lead Plaintiff Deadline: July 11, 2017

GlobeNewswire June 8, 2017

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In Intra-Cellular Therapies, Inc. (Nasdaq: ITCI) To Contact Brower Piven Before The Lead Plaintiff Deadline In Class Action Lawsuit

GlobeNewswire June 7, 2017

IMPORTANT SHAREHOLDER ALERT: Khang & Khang LLP Announces a Securities Class Action Lawsuit against Akari Therapeutics, Plc and Reminds Investors with Losses to Contact the Firm

GlobeNewswire June 6, 2017

EQUITY ALERT: Rosen Law Firm Announces Filing of Securities Class Action Lawsuit Against Barrick Gold Corporation - ABX

GlobeNewswire June 6, 2017